celecoxib has been researched along with Centriacinar Emphysema in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chronic airway inflammation is a characteristic feature of destructive cigarette smoking (CS)-induced lung disease, particularly in patients with emphysema." | 1.36 | Anti-inflammatory effects of celecoxib in rat lungs with smoke-induced emphysema. ( Cho, YJ; Huh, JW; Hwang, YS; Jeon, BT; Kim, HJ; Kim, JH; Lee, JD; Lee, JH; Lee, SD; Nizamudtinova, IT; Oh, YM; Roh, GS; Yi, CO, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roh, GS | 1 |
| Yi, CO | 1 |
| Cho, YJ | 1 |
| Jeon, BT | 1 |
| Nizamudtinova, IT | 1 |
| Kim, HJ | 1 |
| Kim, JH | 1 |
| Oh, YM | 1 |
| Huh, JW | 1 |
| Lee, JH | 1 |
| Hwang, YS | 1 |
| Lee, SD | 1 |
| Lee, JD | 1 |
1 other study available for celecoxib and Centriacinar Emphysema
| Article | Year |
|---|---|
Anti-inflammatory effects of celecoxib in rat lungs with smoke-induced emphysema.
Topics: Animals; Anti-Inflammatory Agents; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Celecoxi | 2010 |